How to translate text using browser tools
1 September 2000 Chemoradiation for Carcinoma of the Cervix: Advances and Opportunities
Patricia J. Eifel
Author Affiliations +
Abstract

Eifel, P. Chemoradiation for Carcinoma of the Cervix: Advances and Opportunities.

Although it is possible to cure many patients with locally advanced cervical cancer using radiation therapy alone, loco-regional relapse continues to be a component of most recurrences. To improve control rates, clinicians have investigated ways of combining chemotherapy and radiation for more than 30 years. Despite encouraging results from phase II trials of neoadjuvant chemotherapy, randomized trials failed to improve on the results with radiation therapy alone. For a number of reasons, early trials of concurrent chemoradiation were inconclusive. However, recent reports of five large prospective randomized trials demonstrated dramatic improvements in survival and local control rates when cisplatin-containing chemotherapy was given during radiation therapy. These results also suggest a number of avenues for future research.

Patricia J. Eifel "Chemoradiation for Carcinoma of the Cervix: Advances and Opportunities," Radiation Research 154(3), 229-236, (1 September 2000). https://doi.org/10.1667/0033-7587(2000)154[0229:CFCOTC]2.0.CO;2
Published: 1 September 2000
RIGHTS & PERMISSIONS
Get copyright permission
Back to Top